BEY1107

DRUG3 trials

Sponsors

BeyondBio Inc.

Conditions

Glioblastoma MultiformeLocally Advanced or Metastatic Pancreatic CancerMetastatic Colorectal Cancer

Phase 1

Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer

RecruitingNCT03579836

BeyondBio Inc.Locally Advanced or Metastatic Pancreatic Cancer

Start: 2018-05-14End: 2026-12-31Target: 75Updated: 2025-03-10

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer

RecruitingNCT05093907

BeyondBio Inc.Metastatic Colorectal Cancer

Start: 2021-08-31End: 2026-12-31Target: 27Updated: 2025-03-10

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

RecruitingNCT05769660

BeyondBio Inc.Glioblastoma Multiforme

Start: 2022-11-29End: 2026-12-31Target: 12Updated: 2025-03-10